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ABSTRACT
Objective Acute pancreatitis is caused by toxins that
induce acinar cell calcium overload, zymogen activation,
cytokine release and cell death, yet is without specific
drug therapy. Mitochondrial dysfunction has been
implicated but the mechanism not established.
Design We investigated the mechanism of induction
and consequences of the mitochondrial permeability
transition pore (MPTP) in the pancreas using cell
biological methods including confocal microscopy, patch
clamp technology and multiple clinically representative
disease models. Effects of genetic and pharmacological
inhibition of the MPTP were examined in isolated murine
and human pancreatic acinar cells, and in
hyperstimulation, bile acid, alcoholic and choline-
deficient, ethionine-supplemented acute pancreatitis.
Results MPTP opening was mediated by toxin-induced
inositol trisphosphate and ryanodine receptor calcium
channel release, and resulted in diminished ATP
production, leading to impaired calcium clearance,
defective autophagy, zymogen activation, cytokine
production, phosphoglycerate mutase 5 activation and
necrosis, which was prevented by intracellular ATP
supplementation. When MPTP opening was inhibited
genetically or pharmacologically, all biochemical,
immunological and histopathological responses of acute
pancreatitis in all four models were reduced or abolished.
Conclusions This work demonstrates the mechanism
and consequences of MPTP opening to be fundamental
to multiple forms of acute pancreatitis and validates the
MPTP as a drug target for this disease.
INTRODUCTION
Pancreatic necrosis, systemic inflammatory response
syndrome, multiple organ failure and sepsis are
characteristic of severe acute pancreatitis (AP),
which results in death of one in four patients and is
without specific drug therapy.1 2 As the pancreatic
acinar cell is an initial site of injury,1 3 commonly
initiated by bile or ethanol excess, investigation of
its behaviour in response to toxins that induce AP
may identify new drug targets. This cell typifies
non-excitable exocrine cells with a high secretory
turnover heavily dependent on mitochondrial pro-
duction of ATP.4 While zymogen activation has
Significance of this study
What is already known on this subject?
▸ Toxins that induce acute pancreatitis cause
pancreatic acinar cell calcium overload,
intracellular zymogen activation, cytokine
release and cell death.
▸ Mitochondrial matrix calcium overload induces
opening of the mitochondrial permeability
transition pore (MPTP), a non-specific inner
mitochondrial membrane channel that causes
loss of mitochondrial membrane potential
essential to ATP production.
▸ Calcium-induced opening of the MPTP occurs
in acute pancreatitis, but the mechanism and
consequences of this process have not been
established.
What are the new findings?
▸ Toxins that cause acute pancreatitis induce the
MPTP in isolated murine and human pancreatic
acinar cells via second messenger receptor
calcium channel release and mitochondrial
calcium but not reactive oxygen species overload,
resulting in mitochondrial depolarisation,
impaired ATP production and necrosis.
▸ Pancreatitis toxin-induced MPTP opening
causes activation of phosphoglycerate mutase
5, which executes necrosis, and retarded
autophagy, which causes accumulation of
activated digestive enzymes.
▸ Specific genetic or pharmacological inhibition
of MPTP opening in a diverse range of clinically
relevant mouse models dramatically improves
all local pancreatic, systemic and distant
pulmonary pathological responses.
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long been considered the principal mechanism of injury,1 3
mitochondrial dysfunction has been implicated increasingly,5–11
presumed consequent upon intracellular calcium overload
induced by toxins that include bile acids and ethanol metabo-
lites.6 11 12 Mitochondrial uptake of calcium drives normal cel-
lular bioenergetics, but high calcium loads induce increasingly
drastic responses culminating in necrosis.13 Mitochondrial
matrix calcium overload leads to opening of the mitochondrial
permeability transition pore (MPTP), a non-specific channel
that forms in the inner mitochondrial membrane allowing
passage of particles under 1500 Da, causing loss of mitochon-
drial membrane potential (Δψm) essential to ATP production;
13
recent evidence implicates F0F1 ATP synthase in MPTP forma-
tion.14 15 MPTP opening is physiological in low conductance
mode releasing calcium and reactive oxygen species (ROS) to
match metabolism with workload,16 but pathological in high
conductance mode compromising ATP production and inducing
cell death;13 both functions are regulated by the mitochondrial
matrix protein peptidyl-prolyl cis-trans isomerase (PPI, cyclophi-
lin) D (also known as cyclophilin F).17
Previous limited studies found that MPTP opening can occur
in pancreatitis;5 9 18 we found cyclophilin D knockout to ameli-
orate AP induced by ethanol and cyclosporine,9 but in a model
with no clinical correlate. How the MPTP is induced in pancre-
atic acinar cells has not been determined, nor what role intracel-
lular calcium might play and whether there are downstream
consequences in AP. Therefore, we sought to undertake a novel,
wide ranging and detailed study to determine the mechanism
and significance of MPTP opening in AP.
We report that MPTP opening is critical to all forms of pan-
creatitis investigated, causing diminished ATP production,
defective autophagy, zymogen activation, cytokine release, phos-
phoglycerate mutase family member 5 (PGAM5) activation19
and necrosis. Pharmacological or genetic MPTP inhibition in
murine or human pancreatic acinar cells protected Δψm, ATP
production, autophagy and prevented necrosis from pancreatitis
toxin-induced calcium release via inositol trisphosphate and rya-
nodine (IP3R, RyR) calcium channels. This mechanism was con-
firmed consistently across four dissimilar, clinically relevant, in
vivo models of AP. All characteristic local and systemic patho-
logical responses were greatly reduced or abolished in cyclophi-
lin D knockout mice (Ppif−/−)20 and wild type (Wt) mice treated
with MPTP inhibitors, confirming that MPTP opening is a fun-
damental pathological mechanism in AP.
METHODS
Animals
Cyclophilin D-deficient mice were generated by targeted disrup-
tion of the Ppif gene20 and provided by Dr Derek Yellon
(University College London, UK) and Dr Michael A Forte
(Oregon Health and Sciences University, USA). Transgenic green
fluorescent protein (GFP)-LC3 mice21 were a gift from Dr N
Mizushima (Tokyo Medical and Dental University and RIKEN
BioResourse Center, Japan). All experiments comparing Wt and
Ppif−/− were conducted using C57BL/6 mice; experiments using
toxins on Wt cells alone used CD1 mice.
Preparation of isolated pancreatic acinar cells and
mitochondria
Normal human pancreata samples (∼1 cm×1 cm×1 mm, not
devascularised during surgery before removal) were placed in a
solution of (mM): 140 NaCl, 4.7 KCl, 1.13 MgCl2, 1 CaCl2,
10 D-glucose, 10 HEPES (adjusted to pH 7.35 using NaOH) at
4°C; sampling to start of cell isolation (or slicing below) was
<10 min in every case. All experiments were at room tempera-
ture (23–25°C, except where stated) and cells used within 4 h of
isolation. Isolation of murine7 and human22 pancreatic acinar
cells was as described. Isolated murine cells were incubated at
37°C in 199 medium with or without 10 nM cholecystokinin-8
(CCK-8) or 500 mM taurolithocholic acid sulfate (TLCS); drug
pretreatment was applied for 30 min. Mitochondria were iso-
lated from mouse pancreata as described.23
Confocal fluorescence microscopy
Cells and tissue were viewed using Zeiss LSM510 and LSM710
systems (Carl Zeiss Jena GmbH), typically with a 63x
C-Apochromat water immersion objective (aperture at 1.2) after
loading with Fluo-4 (3 mM; excitation 488 nm, emission
505 nm) and tetramethyl rhodamine methyl ester (50 nM; exci-
tation 543 nm, emission >550 nm) to assess cytosolic calcium
and mitochondrial membrane potential, with simultaneous mea-
surements of NAD(P)H autofluorescence (excitation 351 nm,
emission 385–470 nm) to assess mitochondrial metabolism. The
protonophore carbonyl cyanide m-chlorophenyl hydrazone
(CCCP) was applied to dissipate Δψm as a positive control.
ROS were assessed after loading with 5-chloromethyl-2,7-
dichlorodihydrofluorescein diacetate acetyl ester (4.5 μM; exci-
tation 488 nm, emission 505–550 nm) for 10 min at 37°C.12
R110-aspartic acid amide (20 μM; excitation 488 nm, emission
>505 nm) and propidium iodide (PI 1 mM; excitation 488 nm,
emission 630–693 nm) were used to assess general caspase acti-
vation and plasma membrane rupture. Thirty random fields of
view were taken of each isolate and the percentage number of
cells displaying caspase activity or PI uptake counted per field,
averaged across fields as mean±SEM (minimum three mice/
group). PI was used in patched cells (below), as was Mg Green
(4 mM, excitation 476 nm, emission 500–550 nm), to monitor
intracellular ATP concentrations.6 Murine pancreas lobules were
incubated with/without 500 μM TLCS and stained with Sytox
Orange24 (500 nM, excitation 543 nm, emission >560 nm),
which like PI only stains cells with ruptured cell membranes:
uptake was determined every two hours by % area tissue
stained.
Patch-clamp current recording
The whole-cell configuration was used to record IClCa from
single cells while recording cytosolic calcium (Fluo-4).25
Patch-pipettes were pulled from borosilicate glass capillaries
Significance of this study
How might it impact on clinical practice in the
foreseeable future?
▸ The demonstration of identical mechanisms in human as in
murine pancreatic acinar cells indicates that the findings that
establish MPTP opening to be of critical importance in
experimental acute pancreatitis are likely to be of major
importance in clinical acute pancreatitis.
▸ This study has shown the effectiveness in experimental acute
pancreatitis of several drugs that target molecules that
regulate the MPTP and that could be developed for the
treatment of clinical acute pancreatitis.
▸ Translational drug discovery and development programmes
that target the MPTP could provide specific, effective
treatments for clinical acute pancreatitis.
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(Harvard Apparatus) with resistance of 2–3 MΩ when filled
with a solution of (mM): 140 KCl; 1.5 MgCl2; 2 MgATP; 10
HEPES; 0.1 ethylene glycol tetraacetic acid, pH 7.2. The
second messenger IP3, cyclic ADP ribose (ADPR) or nicotinic
acid adenine dinucleotide phosphate (NAADP) was added to
the pipette solution at quasi-physiological concentrations (1–
10 μM); in some experiments, MgATP was omitted, while in
others MgATP was raised to 4 mM. Patched cells were exposed
to TLCS (10 mM with second messenger or ACh or CCK-8,
otherwise 200 mM) or palmitoleic acid ethyl ester (POAEE,
10 mM) for 20 min then stained with PI. Whole-cell currents
were sampled at 10 kHz (EPS8 amplifier and Pulse software,
HEKA) from a holding potential of −30 mV, with steps to
+10 mV, beyond the reversal potential (0 mV) of the two
Ca2+-dependent currents through Cl− and non-selective cationic
channels.25
Experimental AP
Caerulein (CER)-AP was induced in male (25–30 g) mice by 7
hourly intraperitoneal injections of 50 μg/kg CER;26 controls
received saline; sacrifice was made 7 h after the first injection
for Ppif−/− comparisons with Wt, or 12 h for assessment of
DEB025 or TRO40303 in Wt. Dosing was determined by prior
pharmacokinetic and pharmacodynamic studies (data not
shown), which identified optimum regimens of 12 hourly injec-
tions of DEB025 at 10 mg/kg or TRO40303 at 3 mg/kg.
TLCS-AP was induced as described27 by retrograde injection of
the pancreatic duct with 3 mM TLCS while controls had ductal
injection of saline; sacrifice was 24 h later. Fatty acid ethyl ester
(FAEE)-AP was induced by 2 hourly intraperitoneal 1.35 g/kg
ethanol and 150 mg/kg palmitoleic acid (POA)11 with controls
receiving saline; sacrifice was 24 h later. Choline-deficient
ethionine-supplemented (CDE)-AP was induced in young
female mice (14–15 g) fasted overnight and fed CDE28 or
regular chow for 48 h, then sacrificed.
Histopathology
Pancreatic necrosis was measured on H&E sections as described
and apoptosis with TUNEL.7 Two independent, blinded investi-
gators scored oedema, leucocyte infiltration and necrosis (0–3)
on ×10 high-power fields/slide/mouse. Scores were summated
(mean±SEM ≥6 mice/group; ≥4 for CDE-AP).
Statistical analysis
Data are presented as mean±SEM. Analysis was by two-tailed
Student’s t test or χ2 test, with p values <0.05 considered
significant.
Study approval
For preparation of pancreas tissue slices and lobules, measure-
ment of isolated mitochondrial responses, electron microscopy,
immunofluorescence, further assessment of disease parameters
in experimental AP and details of chemicals and reagents, see
online supplementary materials.
RESULTS
Pharmacological MPTP inhibition prevents pancreatitis
toxin-induced mitochondrial impairment and necrotic cell
death pathway activation
First, we tested the effect of known MPTP inhibitors on
toxin-induced changes in pancreatic acinar cells using cyclosporin
A (CYA), which binds to and inhibits cyclophilin D, or bongk-
rekic acid (BKA), which favours the closed conformation of
adenine nucleotide translocase.29 We used murine cells hypersti-
mulated with CCK-818 30 to induce cytosolic and mitochondrial
calcium overload,6 12 and found loss of Δψm
7 18 causing
decreases in NAD(P)H (figure 1A), reflecting declining ATP pro-
duction.4 The bile acid TLCS31 induced similar changes (figure
1B). Both CYA and BKA prevented losses of Δψm and NAD(P)H.
TLCS-induced mitochondrial impairment was completely pre-
vented by the calcium chelator 1,2-bis(o-aminophenoxy)
ethane-N,N,N0,N0-tetraacetic acid and was dose dependent (see
online supplementary figure S1). We then tested
D-MeAla3-EtVal4-cyclosporine (Alisporivir, DEB025), which
inhibits cyclophilin D but is not immunosuppressive29 and
3,5-Seco-4-nor-cholestan-5-one oxime-3-ol (TRO40303), which
also inhibits MPTP opening;32 both prevented decreases of Δψm
in murine and freshly isolated human pancreatic acinar cells
(figure 1C). Marked cell death pathway activation was induced
by CCK-8 and TLCS; whereas caspase activation occurred in the
presence of CYA or BKA, PI uptake was largely prevented (figure
1D). Marked protection from TLCS in human pancreatic acinar
cells22 and human pancreas slices followed pretreatment with
CYA, DEB025 and TRO40303 (figure 1E, F).
Genetic MPTP inhibition prevents pancreatitis toxin-induced
mitochondrial impairment and necrotic cell death pathway
activation
Cytosolic calcium changes were significantly less marked in
pharmacologically treated than control cells (seen with CYA and
BKA due to an initial release of calcium from cell stores, but not
with DEB025 or TRO40303, see online supplementary figure
S1), which might reduce mitochondrial calcium loading, so we
examined effects of genetic deletion (Ppif−/−) of cyclophilin D.20
Comparison of Ppif−/− and Wt (C57BL/6) cells showed
CCK-8-induced cytosolic calcium elevations were similar, but in
Ppif−/− calcium clearance was significantly faster (mean±SE area
under curve (F/F0×s) 199.61±26.45 vs 262.35±30.73 in Wt,
p<0.05), a function of calcium ATPase pumps (figure 2A, left).
In Wt cells, Δψm and NAD(P)H fell steadily, but not in Ppif
−/−
(figure 2A, middle and right). TLCS induced similar changes
(figure 2B) with significantly faster calcium clearance in Ppif−/−
cells (243.82±32.34 vs 378.92±45.98 in Wt, p<0.05), despite
little difference detected in mitochondrial calcium loading
(figure 2C, left). Subsequent experiments demonstrated no dif-
ference between Ppif−/− and Wt cells in store-operated calcium
entry or plasma membrane ATPase calcium pump extrusion (see
online supplementary figure S1), consistent with more effective
ATP supply in Ppif−/− compared with Wt cells subjected to
CCK-8- or TLCS-induced calcium overload. As TLCS-induced
ROS increases promote apoptosis not necrosis of pancreatic
acinar cells,12 23 we tested whether ROS increases are greater in
Ppif−/− cells and found no differences from Wt (figure 2C,
middle), ruling this out as a protective mechanism. Ethanol and
POA, which form the toxic FAEE POAEE that induces AP,11 also
caused marked falls of Δψm in Wt not Ppif
−/− cells (figure 2C,
right). There were marked effects of Ppif−/− on PI uptake but
little on general caspase activation (figure 2D), consistent with a
minor role for MPTP opening in pancreatic acinar cell apop-
tosis.7 23 In keeping, cytosolic cytochrome c release was seen in
both Ppif−/− and Wt cells after hyperstimulation, although less
in Ppif−/− cells (figure 2E). We also tested pancreatic lobules,
more closely representing events in vivo, and found necrotic
pathway activation (Sytox Orange uptake)24 markedly inhibited
in Ppif−/− (figure 2F).
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Figure 1 Mitochondrial permeability transition pore (MPTP) inhibitors prevent mitochondrial impairment and necrosis of freshly isolated murine
and human pancreatic acinar cells (confocal fluorescence; mean±SEM ratio to basal, F/F0; n=no. of experiments). (A) Cholecystokinin-8 (CCK-8)
(10 nM) induced large cytosolic calcium elevations (Fluo-4, left), falls in Δψm (tetramethyl rhodamine methyl ester, TMRM; positive control,
protonophore carbonyl cyanide m-chloro phenyl hydrazone, CCCP, middle) and NAD(P)H autofluorescence (right), showing protection of Δψm and
NAD(P)H by cyclosporin A (CYA, 5 mM) or bongkrekic acid (BKA, 50 mM) (pretreatment for 30 min at room temperature during loading of
fluorescent dyes). (B) Taurolithocholic acid sulfate (TLCS) (500 mM) induced similar changes in calcium, Δψm and NAD(P)H, with similar protection
by CYA and BKA. (C) Protection of Δψm from TLCS (500 mM) by pretreatment with DEB025 (100 nM) in murine (left) and human (middle) pancreatic
acinar cells, and with TRO40303 (10 μM, right) in murine cells. (D) CYA or BKA protected cells from early plasma membrane rupture (top, % cells
showing propidium iodide (PI) uptake as inset; *p<0.05 CCK-8 vs control or with inhibitor; †p<0.05 TLCS vs control or with inhibitor) but not from
caspase activation (bottom, % cells showing general caspase substrate fluorescence as inset; *p<0.05, control vs all CCK-8 groups; †p<0.05 control
vs all TLCS groups; white bars=5 μm). (E) Typical rise in TMRM dequench fluorescence31 emitted by normal fresh human pancreatic tissue slice in
response to TLCS (500 μM) and protection by DEB025 (100 nM; upper panel; inset shows confocal image of human pancreatic tissue slice
(mitochondrial (TMRM, red) and nuclear (Hoescht, blue) fluorescent dyes, white bar=15 μm). Lower panel shows protection from TLCS-induced PI
uptake in human pancreatic acinar cells by CYA (100 nM) or DEB025 (100 nM, bottom) and (F) murine (top) and human (bottom) cells by
TRO40303 (10 μM) (*p<0.05 TLCS vs control or with CYA, DEB025 or TRO40303).
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Figure 2 Genetic ablation of cyclophilin D (Ppif−/−) protects pancreatic acinar cells from pancreatitis toxins (fluorescence mean±SEM, F/F0).
(A) Cholecystokinin-8 (CCK-8) (10 nM) induced cytosolic calcium elevations (Fluo-4, left) in Wt (C57BL/6) and Ppif−/− cells, with faster clearance in
Ppif−/−; Δψm (TMRM, middle) and NAD(P)H (right) were preserved in Ppif
−/− not wild type (Wt) cells. (B) Taurolithocholic acid sulfate (TLCS)
(500 mM) induced similar calcium changes, clearing faster in Ppif−/−; whereas Δψm and NAD(P)H were preserved in Ppif
−/− not Wt. (C) TLCS
(500 μM) induced similar mitochondrial calcium elevations (Rhod-2, left) in Ppif−/− and Wt cells, as well as similar reactive oxygen species (ROS)
elevations (DCFDA, middle) in Ppif−/− and Wt cells (menadione, MEN oxidant control); insets show ROS-sensitive DCFDA cell fluorescence (white
bars=10 μm); ethanol (ETOH, 10 mM) and palmitoleic acid (POA, 20 μM) induced falls of Δψm (right) in Wt not Ppif
−/− cells. (D) Significantly
increased propidium iodide (PI) uptake in Wt not Ppif−/− cells after CCK-8 (10 nM) or TLCS (500 mM) (top, *p<0.05 toxin in Wt versus no toxin or
toxin in Ppif−/−), but similar general caspase activation (bottom, *p<0.05 no toxin vs each toxin group). (E) Cyclophilin absence in Ppif−/− pancreas
(immunoblot, left) and cytochrome c (Cyt c) cytosolic fraction immunoblots (densitometry normalised to lactate dehydrogenase (LDH), Cox IV to rule
out mitochondrial contamination, right) showed Cyt c release after CCK-8 by Wt and less by Ppif−/− mitochondria. (F) Necrotic cell death pathway
activation (Sytox Orange; SO) from TLCS (500 mM) was delayed in Ppif−/− vs Wt pancreas lobules (*p<0.05).
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Pancreatitis toxin-induced acinar cell MPTP opening causes
collapse of ATP production and necrotic cell death pathway
activation via second messenger receptor calcium channel
release
As bile acids and FAEEs induce global, prolonged acinar cyto-
solic calcium release via IP3R and RyR calcium channels,
6 33
which causes zymogen activation34 35 dependent on sustained
calcium entry,36 we sought to determine how toxin-induced
calcium release causes mitochondrial injury and pancreatic
acinar cell death. Using patch clamp technology and confocal
microscopy, we observed typical apical stimulus-secretion coup-
ling calcium signals elicited by IP3 (1–10 μM), matched by
calcium-activated Cl− currents4 25 (IClCa). These signals were
promptly transformed into global, prolonged (>30 s) cytosolic
calcium elevations by low concentrations of TLCS (10 μM, 31
of 33 cells, figure 3A, B) or POAEE (10 μM, 34 of 37 cells, see
online supplementary figure S2), followed by PI uptake in Wt
cells (figure 3B and see online supplementary table). Application
of the non-specific IP3R antagonist caffeine
6 inhibited calcium
changes and ICICa from both toxins, preventing PI uptake (22
of 22 cells, figure 3A, see online supplementary figure S2 and
table), demonstrating dependence of toxic transformation on
IP3Rs. Necrotic cell death pathway activation was entirely
dependent on calcium influx (figure 3B and see online
supplementary figure S2). Typical calcium signals and ICICa eli-
cited by the RyR ligand cyclic ADPR (cyclic ADPR, 10 μM)25
were transformed by TLCS (10 μM), not POAEE; those elicited
by NAADP (100 nM)25 were transformed by POAEE (10 μM),
not TLCS (see online supplementary figure S2). To model
events in vivo, quasi-physiological concentrations of CCK-8 or
acetylcholine (ACh) were tested with both toxins, again resulting
in toxic transformation (24 of 24 cells, no patch pipette, figure
3C, see online supplementary figure S2 and table). Without any
second messenger or secretagogue, higher toxin concentrations
(TLCS, 200 μM, figure 3D; POAEE 100 μM, data not shown;
both inhibited by caffeine) were required to induce global, pro-
longed calcium elevations. All protocols that induced such eleva-
tions sustained by external calcium entry resulted in PI uptake
in Wt cells (56 of 60 cells, ≥5 cells with each protocol; figure
3B–D); patched ATP resulted in more efficient calcium clearance
and prevented all PI uptake (46 of 46 Wt cells, ≥4 cells with
each protocol; p<0.0001), and ATP depletion from toxic trans-
formation without patched ATP was confirmed using Mg Green
(figure 3C, see online supplementary figure S2 and table). In all
Ppif−/− cells, there was significantly more efficient calcium clear-
ance, reduced ICICa and return to baseline levels with no PI
uptake, despite no patched ATP (IP3 and TLCS, 10 μM, 17 of
17 cells; TLCS, 200 μM, 7 of 7 cells, figure 3D). These findings
identify a primary role for second messenger calcium channel
release in MPTP opening induced by pancreatitis toxins, result-
ing in declining ATP production and necrosis.
The MPTP determines the sensitivity of pancreatic
mitochondria to calcium overload and PGAM5 induction
To confirm the role of calcium overload in pancreatic acinar cell
MPTP opening, we examined responses of isolated Ppif−/− and
Wt pancreatic mitochondria to external calcium. Ppif−/− and Wt
pancreatic mitochondria demonstrated similar capacity to gener-
ate ATP, as measured by respiration rate in response to ADP
(respiratory control ratio) >3 in the presence of succinate23
(figure 4A). Both types of mitochondria maintained Δψm in zero
or 0.6 μM clamped, free ionised calcium for 10 min; in 1.3 mM
calcium Wt Δψm collapsed, whereas Ppif
−/− Δψm was maintained.
While Wt Δψm was lost after one addition of 25 mM CaCl2,
Ppif−/− Δψm was lost after five successive additions (figure 4B, C).
Ppif−/− pancreatic mitochondria released only 35% less cyto-
chrome c than Wt in 1.3 mM calcium (figure 4D), consistent
with a modest contribution from MPTP opening to cytochrome
c release. To further assess the significance of MPTP opening and
falls in Δψm, we measured levels of PGAM5, a mitochondrial
executor of necrosis.19 Falls in Δψm cause PGAM5 cleavage from
the inner mitochondrial membrane,37 and increases in PGAM5
promote necrosis, facilitating mitochondrial fission.19 After
induction of CER-AP, PGAM5 was increased in Wt but signifi-
cantly less in Ppif−/− pancreata (figure 4E), indicating a mito-
chondrial mechanism for necrosis induced by calcium overload
in AP. These changes were associated with marked ballooning of
and loss of cristae in Wt but not Ppif−/− pancreatic acinar mito-
chondria in CER-AP (figure 4F).
The MPTP mediates zymogen activation through impaired
autophagy
Since zymogen activation is considered essential to AP and
relates to disease severity,1 38–40 we sought to determine
whether and how this is MPTP dependent. We found
CCK-8-induced trypsin activity significantly inhibited in Ppif−/−
compared with Wt (figure 5A), despite no differences in the
amount of trypsinogen (or amylase) between Wt and Ppif−/−
mice pancreata (figure 5B; nor cathepsin B, Bcl-xL or Bcl-2,
data not shown). This finding indicates that MPTP opening con-
tributes to pathological, intra-acinar zymogen activation.
Zymogen activation depends on intracellular calcium overload30
and accumulation of activated zymogens in AP is due to
impaired autophagy.41 We therefore measured levels of
microtubule-associated protein 1A/1B-light chain 3 (LC3),
which in autophagy is converted from cytosolic LC3-I to lipi-
dated LC3-II and recruited into autophagosomal membranes,
and levels of sequestosome 1 (SQSTM1, p62), which sequesters
ubiquitinated protein aggregates to autophagosomes; when
autophagosomes fuse with lysosomes, both LC3-II and p62 are
degraded.42 Following induction of CER-AP that features
marked falls in ATP production, acinar cell vacuolisation and
zymogen activation,7 38 43 significant increases in LC3-II and
p62 occurred in Wt pancreata, showing retarded autophagy
consistent with previous data.41 Increases in LC3-II and p62
were significantly attenuated in Ppif−/− mice (figure 5C–E), indi-
cating more efficient autophagy.42 We confirmed the role of
MPTP opening in defective autophagy using GFP LC3 mice,21
crossed with Ppif−/− mice. Analysis of LC3 puncta (autophagic
vacuoles, figure 5F) as well as increases in LC3-II and p62 in
GFP-LC3 versus GFP-LC3×Ppif−/− mice (≥3 mice/group, data
not shown) confirmed significant attenuation from genetic
inhibition of the MPTP.
Genetic or pharmacological MPTP inhibition sustains ATP
production and confers striking protection from
experimental AP
To determine comprehensively the significance of these mechan-
isms in vivo, we compared responses of Ppif−/− versus Wt mice
in four dissimilar models of AP: CER-AP, TLCS pancreatic
ductal infusion27 (TLCS-AP), ethanol with POA11 (FAEE-AP)
and CDE-AP diet.28 These models represent the whole spectrum
of human AP, including the commonest clinical aetiologies (gall-
stones and ethanol) and extending from mild to lethal disease.
In all models, characteristic changes occurred in serum amylase
and interleukin-6 (IL-6), pancreatic trypsin and myeloperoxi-
dase, pancreatic ATP and histopathology (figures 6 and 7, see
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Figure 3 Pancreatitis toxins accelerate calcium release via second messenger receptors causing collapse of ATP production in wild type (Wt) not
Ppif−/− cells (insets, representative cells, green Fluo-4 and/or red propidium iodide (PI) fluorescence, white bars=10 μm). (A) Typical calcium spikes
(Fluo-4, F/F0, blue) elicited by patched IP3 (1–10 mM) were transformed into global, prolonged elevations upon Taurolithocholic acid sulfate (TLCS)
(10 mM) application, matched by IClCa and non-specific cation currents (−30 mV, black and +10 mV, grey; inset patched cell top), inhibited by
caffeine (Caf, pink); (B) top plot: toxic transformation (IClCa red, no caffeine) showing PI uptake; bottom plot: without external calcium, transformed
signals decreased then disappeared (ICICa black, no PI uptake). (C) Top plot: toxic transformation of acetylcholine (Ach) (20 nM) signals by TLCS
(10 mM), reduced by pipette ATP (4 mM) preventing PI uptake in patched (IClCa and blue calcium trace) but not adjacent (purple calcium trace) cell;
middle plot: toxic transformation of cholecystokinin-8 (CCK-8) (1–5 pM) signals by palmitoleic acid ethyl ester (POAEE, 10 μM) (red IClCa) caused PI
uptake, prevented by pipette ATP (black IClCa, two recordings superimposed); bottom plot: ATP decline (Mg Green; rise indicates increased ADP:ATP
ratio) following toxic transformation (3 pM CCK-8 with 10 mM POAEE; carbonyl cyanide m-chlorophenyl hydrazone induced no further ATP decline).
(D) Top plot: representative trace showing transformation of IP3- (1–10 mM) elicited signal by TLCS (10 mM) did not induce PI uptake in Ppif
−/−
cells, without supplementary ATP; middle plot: TLCS (200 μM) alone induced PI uptake in Wt; bottom plot: TLCS (200 μM) did not induce PI uptake
in Ppif−/− cells.
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Figure 4 Genetic mitochondrial permeability transition pore (MPTP) inhibition confers resistance of pancreatic mitochondria to calcium-induced
loss of Δψm and PGAM5 induction. (A) Representative Clark-type electrode measurement of oxygen consumption showed no difference between
wild type (Wt) and Ppif−/− mitochondria (Mito; succinate=10 mM, ADP=200 μM, carbonyl cyanide m-chlorophenyl hydrazone (CCCP)=2 μM). (B)
Typical TPP+-selective electrode measurement of Δψm with succinate (10 mM) in free ionised calcium clamped at 1.3 mM (calcium/ethylene glycol
tetraacetic acid buffers) for 10 min and (C) during pulses of calcium (25 mM), showing resistance of Ppif−/− mitochondria to loss of Δψm. (D) Δψm
(TPP+-selective electrode, left) and cytochrome c (Cyt c; densitometry from Medium immunoblot, right) in the same preparations, normalised to Wt.
Ppif−/− pancreatic mitochondria release Cyt c but less than Wt (*p<0.05, means±SEM from >3 preparations), as shown in representative Cyt c
immunoblot of medium and mitochondrial pellet (Mito, Cox IV confirmed separation and equal protein loading). (E) Increase in PGAM5 in Wt
caerulein acute pancreatitis (CER-AP) pancreata was significantly reduced in Ppif−/− with representative immunoblot (re-probed for ERK1/2 to
confirm equal loading; each lane from an individual animal; 4–6 mice per group; densitometry of PGAM5 as ratio of band intensities to ERK in each
sample normalised to saline-treated Wt controls, means±SEM; *p<0.01 CER-AP in Wt vs Wt controls, †p<0.05 CER-AP in Ppif−/− vs CER-AP in Wt).
(F) Electron micrographs of pancreata showing Wt and Ppif−/− pancreatic acinar cells after induction of CER-AP compared with saline (SAL) controls.
Wt pancreatic acinar mitochondria are markedly swollen with loss of cristae in CER-AP compared with normal morphology of Ppif−/− pancreatic
acinar mitochondria in CER-AP and in both Wt and Ppif−/− saline controls (M, mitochondrion; N, nucleus; V, vacuole; ZG, zymogen granule; black
bars 1 μm except top right, 2.5 μm).
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online supplementary figures S3 and S4). In contrast, all patho-
logical responses were greatly inhibited in Ppif−/− animals,
including lung myeloperoxidase and IL-6, which mediates lung
injury and lethality.44 In Wt, DEB025 (10 mg/kg) or TRO40303
(3 mg/kg) administered 2 h after the start of hyperstimulation in
CER-AP (figure 6C, D, see online supplementary figure S3) or
1 h after induction of TLCS-AP (figure 7) markedly reduced or
abolished all pathological changes. Protection in TLCS-AP was
close to complete: all changes in Ppif−/− mice or Wt (C57BL/6)
mice treated with DEB025 or TRO40303 were no or minimally
Figure 5 Pancreatitis autophagy impairment and trypsinogen activation are attenuated by genetic mitochondrial permeability transition pore (MPTP)
inhibition (Ppif−/−). (A) Trypsin activity (normalised) following cholecystokinin-8 (CCK-8) (10 nM) hyperstimulation inhibited in Ppif−/− vs wilt-type (Wt)
cells (mean±SEM 6 cell preparations; *p<0.05 Wt CCK-8 vs Wt controls; †p<0.05 Ppif−/− CCK-8 vs Wt CCK-8). (B) Trypsinogen and amylase content
similar in unstimulated and caerulein acute pancreatitis (CER-AP) Wt vs Ppif−/− pancreata (immunoblot; re-probed for ERK1/2 to confirm equal loading;
each lane from an individual animal). (C) Densitometry of LC3-II with (D) representative immunoblots of LC3-II and p62 with (E) densitometry of p62
showing increased levels of these proteins in Wt CER-AP that were both significantly attenuated in Ppif−/− mice, indicating more efficient autophagic
flux (immunoblots re-probed for ERK1/2 to confirm equal loading; each lane from an individual animal; 4–6 mice per group; densitometry of LC3-II or
p62 as ratios of band intensities to ERK in each sample normalised to saline-treated Wt controls, means±SEM; *p<0.01 CER-AP in Wt vs Wt controls,
†p<0.05 CER-AP in Ppif−/− vs CER-AP in Wt). (F) Representative images showing attenuation of CER-AP-induced increases in LC3-II puncta by genetic
MPTP inhibition in green fluorescent protein (GFP)-LC3×Ppif−/− compared with GFP-LC3 transgenic mice (upper panels show LC3 puncta in
saline-treated pancreas and CER-AP for both strains; lower panels show addition of nuclear stain 4’,6-diamidino-2-phenylindole (DAPI)).
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Figure 6 Genetic and pharmacological mitochondrial permeability transition pore (MPTP) inhibition markedly reduces the severity of caerulein acute
pancreatitis (CER-AP). (A) CER-AP resulted in substantial elevations of serum amylase (U/L) and pancreatic trypsin (normalised to wild type (Wt) saline
controls) with substantial reduction in pancreatic ATP content in Wt (*p<0.05) but not Ppif−/− mice (†p<0.05 vs CER-AP in Wt). (B) CER-AP resulted in
substantial elevations of pancreatic (P) and lung (L) myeloperoxidase activity (normalised to CER-AP in Wt at 100) in Wt (*p<0.05) but not Ppif−/− mice
(†p<0.05 vs CER-AP in Wt), while apoptosis scores were significantly increased in CER-AP in both Wt (*p<0.05 vs either control) and Ppif−/− (†p<0.05 vs
either control). (C) Necrosis scores in CER-AP were substantially reduced in Ppif−/− and Wt with DEB025 (10 mg/kg intraperitoneal with third injection of
caerulein) or TRO40303 (3 mg/kg intraperitoneal at same time points) compared to Wt with no treatment (all values means±SEM from ≥6 mice per group
in all experiments; *p<0.01 CER-AP in Wt vs Wt controls; †p<0.05 CER-AP in Ppif−/− or Wt with DEB025 or TRO40303 vs CER-AP in Wt). (D) Normal
pancreatic histology (Wt no treatment) contrasted with CER-AP in Wt, Ppif−/− or Wt treated with DEB025, showing extensive oedema, necrosis and
inflammatory cell infiltration in Wt but not Ppif−/− and not in Wt with DEB025 (H&E, black bars=50 μm).
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Figure 7 Genetic or pharmacological mitochondrial permeability transition pore (MPTP) inhibition abolishes or markedly attenuates biochemical
and histological responses of taurolithocholic acid sulfate acute pancreatitis (TLCS-AP), fatty acid ethyl ester (FAEE)-AP and choline-deficient
ethionine-supplemented (CDE)-AP. (A) Characteristic elevations in TLCS-AP of serum amylase (U/L), interleukin-6 (pg/mL), pancreatic (P)
myeloperoxidase activity (normalised to TLCS-AP in wild type (Wt) at 100) and histology scores (*p<0.05 for all elevations vs sham controls) were
all significantly reduced in Ppif−/− or in Wt treated with DEB025 or TRO40303 (†p<0.05 vs TLCS-AP in Wt without treatment). (B) Characteristic
elevations in lung (L) myeloperoxidase activity (normalised to TLCS-AP in Wt at 100; *p<0.05 vs sham controls) were significantly reduced in Wt
treated with TRO40303 (†p<0.05 vs TLCS-AP in Wt without treatment). (E) Representative histology showing protective effects of Ppif−/− in TLCS-AP,
of DEB025 on TLCS-AP in Wt and of Ppif−/− in FAEE-AP and CDE-AP.
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different from sham controls (figure 7). These findings demon-
strate that inhibition of MPTP opening confers striking local
and systemic protection from pancreatitis. The further new
finding of relative independence of apoptotic processes from the
MPTP (figure 6B) confirmed that apoptosis is not a major con-
tributor to the pathological responses of AP,26 unless it is
massive.45
DISCUSSION
This study demonstrates that MPTP opening is critical to experi-
mental AP, mediating impaired ATP production, defective autop-
hagy, zymogen activation, inflammatory responses and necrosis
(figure 8), features of AP at molecular, cellular and whole organ-
ism levels.1 Our previous work identified metabolic effects of
MPTP opening specific to ethanol. Here we have established the
general significance of MPTP opening as a central mechanism in
the pathogenesis of AP, and the primary role of calcium over-
load in this. The patch clamp data show how tight control of
cytosolic calcium elevations essential to normal stimulus-
secretion coupling by IP3Rs and RyRs
4 is lost in Wt but main-
tained in Ppif−/− pancreatic acinar cells, which preserve ATP
supply and clear calcium more effectively. Coupling of endoplas-
mic reticulum IP3Rs and RyRs with outer mitochondrial mem-
branes tightly localises high calcium concentrations,46 but may
expose mitochondria to abnormal calcium release, despite
modulation by Bcl-2 family proteins.7 Here we have shown that
pancreatitis toxins cause abnormal release of calcium via IP3Rs
and RyRs that overloads pancreatic acinar mitochondria, which
are markedly sensitive to calcium signals.23 The mitochondrial
calcium overload induces high conductance MPTP opening and
dissipates Δψm, initiating collapse of ATP production, dimin-
ished calcium clearance, PGAM5 activation and subsequent
necrosis. Importantly for a disease without specific treatment,
pharmacological MPTP inhibition29 47 administered after AP
induction came close to preventing all injury, notably in the clin-
ically relevant TLCS-AP.
For more than a century following an original postulate by
Chiari,48 pancreatitis has been viewed as an autodigestive
disease consequent on pathological zymogen activation.3 34 38 39 45
In experimental AP, zymogens are activated inside acinar cells
within minutes of toxin exposure,1 3 30 41 which this work has
shown to result from induction of the MPTP, caused by and
contributing to calcium overload. Sustained calcium overload
may activate degradative calpains, phospholipases or other
enzymes17 and damage zymogen granules, inducing autopha-
gic41 and/or endolysosomal49 responses that activate digestive
enzymes. Such activation was not completely prevented by
MPTP inhibition, however, likely from global cytosolic calcium
overload that was seen to be more effectively cleared in Ppif−/−
cells, without which overload no enzyme activation occurs.30
Nevertheless, intracellular expression of trypsin per se without
mitochondrial injury leads to apoptotic not necrotic pathway
activation45 and trypsinogen activation does not appear neces-
sary for either local or systemic inflammation;50 knockout of
cathepsin B greatly reduces trypsinogen activation with little
effect on serum IL-6 or lung injury.39 Hereditary pancreatitis
caused by cationic trypsinogen gene mutations rarely features
clinically significant pancreatic necrosis;51 52 further, systemic
protease inhibition has had little success as a clinical strategy,1
suggesting that while zymogen activation contributes, it is not
the critical driver of AP. This study, however, shows that MPTP
opening triggers defective autophagy, while inhibition of MPTP
opening preserved ATP supply, increased the efficiency of autop-
hagy and decreased zymogen activation. Together with major
effects of MPTP opening on PGAM5 activation that implements
necrosis,19 37 and on local and systemic inflammatory responses,
these findings now place mitochondrial injury centrally in AP.
Our new data show that in pancreatic acinar cells IP3Rs and
RyRs are vulnerable to specific toxins that markedly increase
their calcium channel open-state probabilities. Toxic transform-
ation of calcium channel function induced pancreatic acinar cell
necrosis through calcium-dependent formation of the MPTP,
with diminished ATP production the critical consequence. Toxic
Figure 8 Summary diagram: the
mitochondrial permeability transition
pore (MPTP) plays a critical role in the
development of acute pancreatitis.
Exposure to pancreatic toxins leads to a
sustained rise in cytoplasmic calcium
that crosses the inner mitochondrial
membrane (IMM) to enter the
mitochondrial matrix. Consequent
cyclophilin D (CypD) activation
promotes MPTP opening across the
IMM, causing mitochondrial
depolarisation and impaired ATP
production. These induce PGAM5
activation and retarded autophagy,
downstream mechanisms in acute
pancreatitis (upper panel). When MPTP
opening is inhibited by genetic (Ppif−/−)
or pharmacological means (DEB025 or
TR040303), mitochondrial membrane
potential is preserved and ATP
production sustained. This maintains
the integrity of pancreatic acinar cells
that clear calcium more effectively and
prevents the development of acute
pancreatitis (lower panel) (MPTP drawn
after reference 14).
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transformation by different toxins was specific to different
second messengers, identifying potential for a variety of dele-
terious effects. ATP deficiency may be further exacerbated by
fatty acids released on hydrolysis of FAEEs or triglycerides,53
which may inhibit beta oxidation.6 Without sufficient ATP, cyto-
solic calcium overload produces a vicious circle in which high-
affinity, low-capacity sarcoendoplasmic reticulum calcium trans-
port ATPase (SERCA) and plasma membrane calcium ATPase
(PMCA) pump clearance of cytosolic calcium is impaired,
further mitochondrial injury sustained and necrotic cell death
accelerated.6 12 Although the toxicity of cytosolic calcium over-
load depends on calcium store refilling from outside the
cell,30 54 specific second messenger receptor blockade demon-
strated calcium overload to be due completely to release from
their calcium channels, not direct effects of toxins on calcium
entry or extrusion.
Whereas the vast majority of previous studies undertaken to
determine mechanisms and/or new targets in AP have used only
one model, our four models are broadly representative of a
range of aetiologies, including biliary (TLCS-AP), hyperstimula-
tion (CER-AP), ethanolic (FAEE-AP) and amino acid-induced
(CDE-AP).1 55 Our findings in experimental AP are entirely con-
sistent with those made in isolated mitochondria and cells, iden-
tifying a generalised mechanism of pancreatic injury and
necrosis, confirmed in murine and human pancreatic acinar
cells, pancreas lobules and tissue slices. Pancreatic necrosis
drives the inflammasome,56 which can be induced by MPTP
opening57 and is part of the systemic inflammatory response
contributing to multiple organ failure.2 Further pancreatic
injury is driven through tumour necrosis factor receptor activa-
tion that also promotes MPTP opening58 and calcium deregula-
tion, activating calcineurin and NFAT.59 Our data link necrosis
and inflammation directly, highlighting the potential of the
MPTP as a drug target for AP.
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